U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 218213

AUGTYRO (REPOTRECTINIB)
40MG
Marketing Status: Prescription
Active Ingredient: REPOTRECTINIB
Proprietary Name: AUGTYRO
Dosage Form; Route of Administration: CAPSULE; ORAL
Strength: 40MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N218213
Product Number: 001
Approval Date: Nov 15, 2023
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top